Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,454 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,230 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06168890 | Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure. | completed | — | 195 | IRCCS San RaffaeleOTHER | 0 | Dec 13, 2023 | clinicaltrials |
| NCT03113617 | 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer | completed | Phase 2 | 44 | Andrei IagaruOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT05294627 | Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population | completed | — | 380 | University Hospital, Basel, SwitzerlandOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT03871816 | A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer | completed | — | 14,532 | Janssen Research & Development, LLCINDUSTRY | 25 | Dec 11, 2023 | clinicaltrials |
| NCT04535921 | Fear of Cancer Recurrence in Genitourinary Cancer | completed | — | 500 | Ludwig-Maximilians - University of MunichOTHER | 1 | Dec 11, 2023 | clinicaltrials |
| NCT02061345 | PET Imaging in MCI Following ADT for PCa | completed | — | 11 | Imperial College LondonOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT00791115 | Salvage Prostatectomy After Radiotherapy | completed | N/A | 16 | University Health Network, TorontoOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT00915122 | Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate | completed | Phase 1 / Phase 2 | 81 | University Health Network, TorontoOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT06158178 | Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer. | completed | — | 520 | IRCCS San RaffaeleOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT00818623 | Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients | completed | Phase 2 | 172 | Ferring PharmaceuticalsINDUSTRY | 7 | Nov 30, 2023 | clinicaltrials |
| NCT00819156 | Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer | completed | Phase 2 | 189 | Ferring PharmaceuticalsINDUSTRY | 8 | Nov 30, 2023 | clinicaltrials |
| NCT03682146 | Laparoscopic vs Robotic-Assisted Radical Prostatectomy(LAP-01) | completed | N/A | 782 | University of LeipzigOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT01187485 | A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer | completed | Phase 1 | 15 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT03001869 | 68Ga-PSMA PET/CT in Prostate Cancer | completed | Phase 3 | 540 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT00482807 | Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer | completed | Phase 1 | 9 | University of NebraskaOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT00584532 | Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.(GCP) | completed | Phase 2 / Phase 3 | 66 | University of California, DavisOTHER | 0 | Nov 24, 2023 | clinicaltrials |
| NCT01682941 | Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen | completed | N/A | 32 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03149185 | Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer(PC-CHIP) | completed | N/A | 224 | Northwestern UniversityOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03513211 | Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer(HITMAN-PC) | completed | Phase 1 / Phase 2 | 12 | St Vincent's Hospital, SydneyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04863352 | Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA(OPS) | completed | — | 657 | Sykehuset Innlandet HFOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05489341 | Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge | completed | — | 10,207 | Radboud University Medical CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT01972217 | Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer. | completed | Phase 2 | 158 | AstraZenecaINDUSTRY | 11 | Nov 14, 2023 | clinicaltrials |
| NCT03176381 | Tissue Predictors of Abiraterone Benefit | completed | — | 110 | Tianjin Medical University Second HospitalOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT00541047 | RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | completed | Phase 3 | 4,236 | University College, LondonOTHER | 2 | Nov 13, 2023 | clinicaltrials |
| NCT05197257 | 68Ga-PSMA-11 PET in Patients With Prostate Cancer | completed | Phase 3 | 39 | University of Colorado, DenverOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT00819247 | The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer | completed | Phase 2 | 129 | Ferring PharmaceuticalsINDUSTRY | 1 | Nov 9, 2023 | clinicaltrials |
| NCT02578797 | A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study | completed | Phase 1 | 45 | Aragon Pharmaceuticals, Inc.INDUSTRY | 5 | Nov 9, 2023 | clinicaltrials |
| NCT02713022 | Body Composition and White Adipose Tissue Inflammation | completed | — | 202 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT00587431 | Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer | completed | Phase 2 | 102 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06119438 | Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy | completed | N/A | 120 | Mersin Training and Research HospitalOTHER_GOV | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03396874 | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence | completed | Phase 2 | 1,435 | University of MichiganOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06116344 | Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier | completed | — | 173 | Paracelsus Medical UniversityOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT00337155 | BAY88-8223, Dose Finding Study in Patients With HRPC | completed | Phase 2 | 122 | BayerINDUSTRY | 1 | Nov 2, 2023 | clinicaltrials |
| NCT00020046 | Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT03840200 | A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. | completed | Phase 1 | 51 | Hoffmann-La RocheINDUSTRY | 5 | Oct 30, 2023 | clinicaltrials |
| NCT00590993 | Magnetic Resonance Imaging and Spectroscopy of the Prostate | completed | — | 1,005 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT02070575 | Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT06092918 | Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy. | completed | — | 700 | Consorci Sanitari de TerrassaOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT03477591 | Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | completed | N/A | 308 | McMaster UniversityOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT01956058 | Brachytherapy for Recurrent Prostate Cancer(CAPRICUR) | completed | Phase 2 | 30 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT03830164 | Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer | completed | Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT03751436 | Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT04441775 | Artificial Intelligence for Prostate Cancer Treatment Planning | completed | — | 5 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT03370016 | The Impact of Low Pressure Pneumo in RARP | completed | N/A | 222 | Metro Health, MichiganOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04534309 | Behavioral Weight Loss Program for Cancer Survivors in Maryland(ASPIRE) | completed | N/A | 340 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT02987543 | Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) | completed | Phase 3 | 387 | AstraZenecaINDUSTRY | 20 | Oct 6, 2023 | clinicaltrials |
| NCT05725070 | Phase 0/1 Study of 212Pb-NG001 in mCRPC | completed | Early Phase 1 | 3 | ARTBIO Inc.INDUSTRY | 1 | Oct 6, 2023 | clinicaltrials |
| NCT04124900 | Telomere Associated Variables (TAVs) in Prostate Cancer | completed | — | 509 | Life Length SLINDUSTRY | 2 | Oct 5, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Dec 13, 2023source: clinicaltrials